The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Life histories of myeloproliferative neoplasms inferred from phylogenies
Open accessPublished version of a preprint
Abstract
Mutations in cancer-associated genes drive tumour outgrowth, but our knowledge of the timing of driver mutations and subsequent clonal dynamics is limited 1-3. Here, using whole-genome sequencing of 1,013 clonal haematopoietic colonies from 12 patients with myeloproliferative neoplasms, we identified 580,133 somatic mutations to reconstruct haematopoietic phylogenies and determine clonal histories. Driver mutations were estimated to occur early in life, including the in utero period. JAK2 V617F was estimated to have been acquired by 33 weeks of gestation to 10.8 years of age in 5 patients in whom JAK2 V617F was the first event. DNMT3A mutations were acquired by 8 weeks of gestation to 7.6 years of age in 4 patients, and a PPM1D mutation was acquired by 5.8 years of age. Additional genomic events occurred before or following JAK2 V617F acquisition and as independent clonal expansions. Sequential driver mutation acquisition was separated by decades across life, often outcompeting ancestral clones. The mean latency between JAK2 V617F acquisition and diagnosis was 30 years (range 11-54 years). Estimated historical rates of clonal expansion varied substantially (3% to 190% per year), increased with additional driver mutations, and predicted latency to diagnosis. Our study suggests that early driver mutation acquisition and life-long growth and evolution underlie adult myeloproliferative neoplasms, raising opportunities for earlier intervention and a new model for cancer development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Emerging evidence indicates somatic DNMT3A variants can be acquired early in life (12,13), before becoming almost ubiquitous in the aging population (14).”
From Txnip Enhances Fitness of Dnmt3a -Mutant Hematopoietic Stem Cells via p21 (2022) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Stan : A Probabilistic Programming Language
Carpenter, B., Gelman, A., Hoffman, M. D., Lee, D., Goodrich, B., Betancourt, M., Brubaker, M., Guo, J., Li, P., & Riddell, A. (2017) · Journal of Statistical Software · doi:10.18637/jss.v076.i01 · Cited by 7,754
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Pan-cancer analysis of whole genomes
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Aaltonen, L. A., Abascal, F., Abeshouse, A., Aburatani, H., Adams, D. J., Agrawal, N., Ahn, K. S., Ahn, S.-M., Aikata, H., et al. (2020) · Nature · doi:10.1038/s41586-020-1969-6 · Cited by 3,064
Ye, K., Schulz, M. H., Long, Q., Apweiler, R., & Ning, Z. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp394 · Cited by 2,029
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
High burden and pervasive positive selection of somatic mutations in normal human skin
Martincorena, I., Roshan, A., Gerstung, M., Ellis, P., Van Loo, P., McLaren, S., Wedge, D. C., Fullam, A., Alexandrov, L. B., Tubio, J. M., et al. (2015) · Science · doi:10.1126/science.aaa6806 · Cited by 1,770
Self-citationSomatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
Nangalia, J., Massie, C. E., Baxter, E. J., Nice, F. L., Gundem, G., Wedge, D. C., Avezov, E., Li, J., Kollmann, K., Kent, D. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1312542 · Cited by 1,756
Self-citationThe origin and evolution of mutations in acute myeloid leukemia
Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575
Cited by
Sorted by citations
Items 101–200 of 284
Cancer and aging: A call to action
Braithwaite, D., Anton, S. D., Mohile, S. G., DeGregori, J. V., Gillis, N., Zhou, D., Bloodworth, S., Pahor, M., & Licht, J. D. (2022) · Aging and Cancer · doi:10.1002/aac2.12055 · Cited by 13
The Crossroads of Clonal Evolution, Differentiation Hierarchy, and Ontogeny in Leukemia Development
Sturgeon, C. M., Wagenblast, E., Izzo, F., & Papapetrou, E. P. (2024) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-24-0235 · Cited by 12
Determinants of mosaic chromosomal alteration fitness
Pershad, Y., Mack, T., Poisner, H. M., Jakubek, Y. A., Stilp, A. M., Mitchell, B. D., Lewis, J. P., Boerwinkle, E., Loos, R. J. F., Chami, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48190-8 · Cited by 13
Quantifying cell divisions along evolutionary lineages in cancer
Blohmer, M., Cheek, D. M., Hung, W.-T., Kessler, M., Chatzidimitriou, F., Wang, J., Hung, W., Lee, I., Gorelick, A. N., Wassenaar, E. C. E., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02078-5 · Cited by 12
Kim, T. Y., Kwag, D., Lee, J., Lee, J., Min, G. J., Park, S., Park, S., Jeon, Y., Yoon, J., Shin, S.-H., et al. (2022) · Cancers · doi:10.3390/cancers14184485 · Cited by 12
Self-citationVEXAS Syndrome in a Patient with Myeloproliferative Neoplasia
Austestad, J., Madland, T. M., Sandnes, M., Haslerud, T. M., Benneche, A., & Reikvam, H. (2023) · Case Reports in Hematology · doi:10.1155/2023/6551544 · Cited by 12
Recent advances in therapies for primary myelofibrosis
Vainchenker, W., Yahmi, N., Havelange, V., Marty, C., Plo, I., & Constantinescu, S. N. (2023) · Faculty Reviews · doi:10.12703/r/12-23 · Cited by 11
Brain injury drives optic glioma formation through neuron-glia signaling
Chatterjee, J., Koleske, J. P., Chao, A., Sauerbeck, A. D., Chen, J., Qi, X., Ouyang, M., Boggs, L. G., Idate, R., Marquez, L. I. M. Y., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01735-w · Cited by 11
Clinical and Therapeutic Implications of Clonal Hematopoiesis
Petrone, G. E. M., Turker, I., Natarajan, P., & Bolton, K. L. (2024) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120722-100409 · Cited by 11
Mangaonkar, A. A., & Patnaik, M. M. (2022) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2022.2056175 · Cited by 11
Rapamycin treatment during development extends lifespan and healthspanPreprint
Shindyapina, A. V., Cho, Y., Kaya, A., Tyshkovskiy, A., Castro, J. P., Gordevičius, J., Poganik, J. R., Horvath, S., Peshkin, L., & Gladyshev, V. N. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.18.481092 · Cited by 11
Cull, A. H., Kent, D. G., & Warren, A. J. (2024) · Blood · doi:10.1182/blood.2023019986 · Cited by 10
Schafer, A. I., & Mann, D. L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206084 · Cited by 10
Watt, S. M., Peng, H., & Roberts, I. A. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073675 · Cited by 9
Rontauroli, S., Carretta, C., Parenti, S., Bertesi, M., & Manfredini, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315256 · Cited by 12
Cannabis genotoxicity and cancer incidence: Highly concordant synthesis of European and USA datasets
Reece, A. S., & Hulse, G. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89862-1.00028-3 · Cited by 9
Clonal hematopoiesis and bone marrow inflammation
Xie, X., Su, M., Ren, K., Ma, X., Lv, Z., Li, Z., Mei, Y., & Ji, P. (2022) · Translational research · doi:10.1016/j.trsl.2022.11.004 · Cited by 10
How I treat patients with low-risk polycythemia vera who require cytoreduction
McMullin, M. F., & Harrison, C. N. (2024) · Blood · doi:10.1182/blood.2023022418 · Cited by 9
King, Z., Desai, S. R., Frank, D. A., & Shastri, A. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101137 · Cited by 11
Brierley, C. K., Yip, B. H., Orlando, G., Wen, J. Q., Wen, S., Goyal, H., Levine, M. F., Jakobsdottir, G. M., Tapinos, A., Cornish, A. J., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02190-6 · Cited by 13
A phylogenetic approach to inferring the order in which mutations arise during cancer progression
Gao, Y., Gaither, J., Chifman, J., & Kubatko, L. S. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010560 · Cited by 11
Molecular‐defined clonal evolution in patients with classical myeloproliferative neoplasms
Hinze, A., Rinke, J., Crodel, C. C., Möbius, S., Schäfer, V., Heidel, F. H., Hochhaus, A., & Ernst, T. (2023) · British Journal of Haematology · doi:10.1111/bjh.18834 · Cited by 9
Schuermans, A., Nakao, T., Ruan, Y., Koyama, S., Yu, Z., Uddin, M. M., Haidermota, S., Hornsby, W., Lewandowski, A. J., Bick, A. G., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030220 · Cited by 11
Polycythemia vera: past, present and future
Patel, A. B., Masárová, L., Mesa, R. A., Hobbs, G. S., & Pemmaraju, N. (2024) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2024.2361836 · Cited by 10
Spatial Mapping of Hematopoietic Clones in Human Bone Marrow
Young, A. L., Davis, H. C., Cox, M. J., Parsons, T. M., Burkart, S. C., Bender, D. E., Sun, L., Oh, S. T., & Challen, G. A. (2024) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-23-0110 · Cited by 8
Decoding Clonal Hematopoiesis: Emerging Themes and Novel Mechanistic Insights
Pendse, S., & Loeffler, D. (2024) · Cancers · doi:10.3390/cancers16152634 · Cited by 8
Pasquier, F., Pegliasco, J., Martin, J., Marti, S., & Plo, I. (2024) · Haematologica · doi:10.3324/haematol.2023.283958 · Cited by 10
Chen, M., Zheng, C., Zhang, Y., He, J., & Shi, Z. (2025) · Mediators of Inflammation · doi:10.1155/mi/9967975 · Cited by 10
Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulation
Agarwal, G., Antoszewski, M., Xie, X., Pershad, Y., Arora, U. P., Poon, C.-L., Lyu, P., Lee, A. J., Guo, C., Ye, T., et al. (2026) · Science · doi:10.1126/science.adx4174 · Cited by 10
Clonal Hematopoiesis: Origins and determinants of evolution
Mendez, L., & Patnaik, M. M. (2023) · Leukemia Research · doi:10.1016/j.leukres.2023.107076 · Cited by 8
The impact of prenatal inflammation on hematopoietic development
Tseng, N. A., & Beaudin, A. E. (2023) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000770 · Cited by 8
Single-cell DNA sequencing reveals pervasive positive selection throughout preleukemic evolution
Poon, G. Y. P., Vedi, A., Sanders, M. A., Laurenti, E., Valk, P. J. M., & Blundell, J. R. (2025) · Cell Genomics · doi:10.1016/j.xgen.2024.100744 · Cited by 8
Kalmer, M., Pannen, K., Lemanzyk, R., Wirths, C., Baumeister, J., Maurer, A., Kricheldorf, K., Schifflers, J., Gezer, D., Isfort, S., et al. (2022) · Annals of Hematology · doi:10.1007/s00277-022-05000-9 · Cited by 8
O’Connor, D., Valle-Inclán, J. E., Conde, L., Bloye, G., Rahman, S., Costa, J. R., Bartram, J. L., Adams, S. P., Wright, G., Elrick, H., et al. (2024) · Blood · doi:10.1182/blood.2023021906 · Cited by 9
scMitoMut for calling mitochondrial lineage-related mutations in single cells
Sun, W., van Ginneken, D., & Perié, L. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf072 · Cited by 7
Clonal expansion in normal tissues
Maeda, H., & Kakiuchi, N. (2024) · Cancer Science · doi:10.1111/cas.16183 · Cited by 7
Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome
Díez-Díez, M., Amorós-Pérez, M., de la Barrera, J., Vázquez, E., Quintas, A., Pascual-Figal, D. A., Dopazo, A., Sánchez‐Cabo, F., Kleinman, M. E., Gordon, L. B., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00607-2 · Cited by 8
Lineage Tracing and Molecular Real-Time Imaging of Cancer Stem Cells
Jia, X., Shen, G., Jia, J., Zhang, Y., Zhang, D., Li, W., Zhang, J., Huang, X., & Tian, J. (2022) · Biosensors · doi:10.3390/bios12090703 · Cited by 7
Haughey, M. J., Bassolas, A., Sousa, S., Baker, A., Graham, T. A., Nicosia, V., & Huang, W. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010952 · Cited by 7
Optimizing IFN Alpha Therapy against Myeloproliferative Neoplasms
Hermange, G., Cournède, P.-H., & Plo, I. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001561 · Cited by 7
Holl, K., Chatain, N., Krapp, S., Baumeister, J., Maié, T., Schmitz, S. M., Scheufen, A., Brock, N., Koschmieder, S., & Moreno-Andrés, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-53240-8 · Cited by 7
Myeloproliferative Neoplasms: Challenging Dogma
Spivak, J. L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226957 · Cited by 6
INCA033989: the first shot on goal for MPNs?
Benlabiod, C., & Psaila, B. (2024) · Blood · doi:10.1182/blood.2024026811 · Cited by 6
Molecular profiling in MPN: who should have it and why?
Chee, A., & Mead, A. J. (2024) · Hematology · doi:10.1182/hematology.2024000576 · Cited by 6
Abu-Zeinah, G. F., Erdos, K., Lee, N., Ganom, Y., Klade, C. S., Krejcy, K., Gisslinger, H., Silver, R. T., & Scandura, J. M. (2025) · Blood · doi:10.1182/blood.2024027528 · Cited by 6
Aggressive cholesterol lowering normalizes atherosclerosis regression in Jak2V617F mice
Hardaway, B. D., Fidler, T. P., Tavallaie, M. S., Hsu, C.-C., Schiavone, S., Xiao, T., Wang, R., Wang, N., & Tall, A. R. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101003 · Cited by 6
Garrote, M., López‐Guerra, M., García‐Pagán, J. C., Arellano‐Rodrigo, E., Ferrer‐Marín, F., Hernández‐Boluda, J. C., Bellosillo, B., Nomdedéu, M., Hernández–Gea, V., Triguero, A., et al. (2024) · Annals of Hematology · doi:10.1007/s00277-023-05610-x · Cited by 6
Progressive disruption of hematopoietic architecture from clonal hematopoiesis to MDS
Buck, M. C., Bast, L., Hecker, J. S., Rivière, J., Rothenberg‐Thurley, M., Vogel, L., Wang, D., Andrä, I., Theis, F. J., Bassermann, F. C., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107328 · Cited by 6
Molecular Studies for the Early Detection of Philadelphia-Negative Myeloproliferative Neoplasms
Stuckey, R., Bilbao, C., Segura-Díaz, A., & Gómez‐Casares, M. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612700 · Cited by 6
Fulvio, G., Baldini, C., Mosca, M., Paolo, A. D., Bocci, G., Palumbo, G. A., Cacciola, E., Migliorini, P., Cacciola, R. R., & Galimberti, S. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1254868 · Cited by 7
JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander?
Tarantini, F., Cumbo, C., Zagaria, A., Parciante, E., Anelli, L., Coccaro, N., Tota, G., Minervini, C. F., Redavid, I., Rossi, A. R., et al. (2022) · Hematology · doi:10.1080/16078454.2022.2108902 · Cited by 6
Clonal Hematopoiesis in Women With Breast Cancer
Mayerhofer, C., Freedman, R. A., Parsons, H. A., Partridge, A. H., & Miller, P. G. (2025) · Journal of Clinical Oncology · doi:10.1200/jco-24-01848 · Cited by 5
Modeling the evolutionary dynamics of clonal hematopoiesis
Marzban, S., Stiehl, T., Xie, Z., Andersen, M., Snyder, J. A., Gudmand‐Hoeyer, J., Ottesen, J. T., Père, N. V. M., Werner, B., Huang, W., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02504-2 · Cited by 7
Kucine, N., Jessup, J. A., Cooper, T. M., Urbanski, R. W., Kolb, E. A., & Resar, L. M. S. (2023) · Pediatric Blood & Cancer · doi:10.1002/pbc.30559 · Cited by 5
Takamori, H., Huang, Y., Fukushima, H., Yokoyama, K., Huang, T., Kuo, M., Ogawa, S., Nannya, Y., & Shih, L. (2025) · Leukemia · doi:10.1038/s41375-025-02576-9 · Cited by 5
JAK-2 V617F Mutation in Endothelial Cells of Patients with Atherosclerotic Carotid Disease
Küçükkaya, R. D., İyigün, T., Albayrak, Ö., Eker, C., & Günel, T. (2024) · Turkish Journal of Hematology · doi:10.4274/tjh.galenos.2024.2024.0161 · Cited by 6
Zhuang, Q., Jin, S., Wang, W., Wang, Y., Tong, H., Liu, Z., & Sun, J. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.10.005 · Cited by 5
Bellosillo, B., Doubek, M., Tomuleasa, C., Grießhammer, M., Marchetti, M., Sacha, T., & Gisslinger, H. (2024) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-024-01009-0 · Cited by 7
Kjær, L., Skov, V., Larsen, M. K., Boklund, T. I., Andersen, M., Kefala, M. A., Knudsen, T. A., Eickhardt‐Dalbøge, C. S., Stiehl, T., Gudmand‐Hoeyer, J., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1176173 · Cited by 5
Large-scale single-cell phylogenetic mapping of clonal evolution in the human aging esophagusPreprint
Prieto, T., Yuan, D. J., Zinno, J., Hughes, C., Midler, N., Kao, S., Huuhtanen, J., Raviram, R., Fotopoulou, F., Ruthen, N. G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.11.681805 · Cited by 9
Emerging insights into mosaic errors of immunity
Roosens, W., Demeulemeester, J., Legius, E., Savic, S., & Schrijvers, R. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.09.003 · Cited by 5
Brain somatic mutations in Alzheimer’s disease: linking genetic mosaicism to neurodegeneration
Li, Z., Zhang, J., Liu, Z., Yu, L., Yang, C., Zhang, L., Xiang, Z., Hu, F., Brazh, N., Shu, K., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00895-0 · Cited by 6
Medeiros, J. J. F., Zeng, A. G. X., Bansal, S., Kim, H., Chan‐Seng‐Yue, M., Woo, T., McLeod, J. L., Kothari, S. P., Arruda, A., Tsui, H., et al. (2026) · Blood · doi:10.1182/blood.2025030094 · Cited by 4
Bonal, D. M., Oakes, A., Chorzalska, A. D., Pardo, M. R., Petersen, M., Clarke, M. Y., Lee, S.-H., Olszewski, A. J., Treaba, D. O., Reagan, J. L., et al. (2025) · Blood · doi:10.1182/blood.2024027125 · Cited by 4
Zhao, Y., Wang, D., Liang, Y., Xu, Z., Shi, L., & Tong, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.927018 · Cited by 4
Are we ready for disease modification in myeloproliferative neoplasms?
Harrison, C. N. (2024) · HemaSphere · doi:10.1002/hem3.70003 · Cited by 4
Wang, Y., Wei, C., Lin, C., Gurnari, C., Awada, H., Benajiba, L., Oliveira, R. D. D., Soret‐Dulphy, J., Cassinat, B., Žučenka, A., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02422-4 · Cited by 4
Baker, J. L., Gordon-Dseagu, V., Voortman, T., Chan, D. S. M., Herceg, Z., Robinson, S. M., Norat, T., Croker, H. A., Ong, K. K., & Kampman, E. (2025) · Health Open Research · doi:10.12688/healthopenres.13748.2 · Cited by 4
Zuriaga, M. A., & Fuster, J. J. (2025) · Diabetologia · doi:10.1007/s00125-025-06393-8 · Cited by 6
Clonal hematopoiesis of indeterminate potential and atrial fibrillation
Liu, J., Zhang, N., Teng, G., Tse, G., Bai, J., Lip, G. Y. H., & Liu, T. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.05.011 · Cited by 4
“ASXL1”-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms
Gleitz, H. F. E., & Schneider, R. K. (2022) · Haematologica · doi:10.3324/haematol.2022.281634 · Cited by 4
Evolutionary dynamics of 1,976 lymphoid malignancies predict clinical outcomePreprint
Gabbutt, C., Duran‐Ferrer, M., Grant, H. E., Mallo, D., Nadeu, F., Househam, J., Villamor, N., Krali, O., Nordlund, J., Zenz, T., et al. (2023) · medRxiv · doi:10.1101/2023.11.10.23298336 · Cited by 4
Brierley, C. K., Yip, B., Orlando, G., Goyal, H., Wen, S., Wen, J., Levine, M., Jakobsdottir, G. M., Rodríguez-Meira, A., Adamo, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.08.570880 · Cited by 4
Toward a Unified Theory of Why Young People Develop CancerPreprint
Kentsis, A. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041658 · Cited by 4
Tian, S., Jenkinson, G., Ferrer, A., Yan, H., Morales‐Rosado, J. A., Wang, K. L., Lasho, T. L., Yan, B. B., Baheti, S., Olson, J. E., et al. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf040 · Cited by 3
Clonal Dynamics of Hematopoiesis in Aplastic Anemia after Immunosuppression and Eltrombopag
Kaya, D. E., Cook, R., Iacobelli, S., Napolitani, G., Gerlevik, S., Seymen, N., de Fontbrune, F. S., Griffin, M., Frieri, C., Halkes, C. J. M., et al. (2026) · NEJM Evidence · doi:10.1056/evidoa2500174 · Cited by 3
Efficient reconstruction of cell lineage trees for cell ancestry and cancer
Jang, Y., Fasching, L., Bae, T., Tomasini, L., Schreiner, J. D., Szekely, A. M., Fernandez, T. V., Leckman, J. F., Vaccarino, F. M., & Abyzov, A. S. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad254 · Cited by 3
Ultraviolet light shapes the evolution of precancerous cells
Papaemmanuil, E. (2023) · Nature · doi:10.1038/d41586-023-01815-2 · Cited by 3
Müskens, K. F., Wieringa, N., van Bergen, M. G. J. M., Bense, J. E., Pas, B. M. T., de Pagter, A. P. J., Lankester, A. C., Bierings, M., Neuberg, D. S., Haitjema, S., et al. (2025) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-24-0136 · Cited by 5
The etiology of clonal mosaicism in human aging and disease
Massaar, S., & Sanders, M. A. (2023) · Aging and Cancer · doi:10.1002/aac2.12061 · Cited by 4
Inflammation and bone marrow fibrosis: novel immunotherapeutic targets
Calledda, F. R., Malara, A., & Balduini, A. (2023) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000778 · Cited by 3
Moura, P. L., Nannya, Y., Aliouat, A., Hofman, I. J., Blanco, T. M., Yoshizato, T., Saiki, R., Nakagawa, M. M., Creignou, M., Björklund, A.-C., et al. (2024) · Blood Neoplasia · doi:10.1016/j.bneo.2024.100011 · Cited by 3
Multifocal, multiphenotypic tumours arising from an MTOR mutation acquired in early embryogenesis
Pacyna, C. N., Anandapadamanaban, M., Loudon, K. W., Hay, I. M., Perišić, O., Li, R., Byrne, M., Allen, L., Roberts, K., Hooks, Y. E., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03137-7 · Cited by 3
Self-citationAoun, C., Maslah, N., Ganesan, S., Salomao, N., Gendron, R., Awan-Toor, S., Letort, G., Gou, P., Bonnamy, M., Parietti, V., et al. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70138 · Cited by 3
Evolution of myeloproliferative neoplasms from normal blood stem cells
Hormoz, S., Sankaran, V. G., & Mullally, A. (2024) · Haematologica · doi:10.3324/haematol.2023.283951 · Cited by 3
Shivarov, V. S., Tsvetkova, G., Micheva, I., Hadjiev, E. A., Petrova, J., Ivanova, A., Madjarova, G. K., & Ivanova, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1427810 · Cited by 4
Costa, A. N., & Breccia, M. (2025) · Cancers · doi:10.3390/cancers17213397 · Cited by 2
Ellis, M. H., Barbui, T., & Tefferi, A. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2026.01.008 · Cited by 2
No evidence of immunosurveillance in mutation-hotspot-driven clonal hematopoiesis
Walkowiak, B., MacGregor, H. A. J., & Blundell, J. R. (2026) · Nature Genetics · doi:10.1038/s41588-026-02594-y · Cited by 4
Plo, I., & Vainchenker, W. (2026) · New England Journal of Medicine · doi:10.1056/nejmra2507867 · Cited by 2
A single-cell lens into the co-evolution of genotypes and phenotypes in cancer
Izzo, F., Prieto, T., Potenski, C. J., & Landau, D. A. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00970-8 · Cited by 2
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice
Fisher, D. A. C., Laranjeira, A. B. A., Kong, T., Snyder, S. C., Shim, K., Fulbright, M. C., & Oh, S. T. (2023) · Experimental Hematology · doi:10.1016/j.exphem.2023.08.005 · Cited by 2
Molecular pathogenesis of myeloproliferative neoplasms: Where do we stand in 2023?
Havelange, V., & Constantinescu, S. N. (2023) · American Journal of Hematology · doi:10.1002/ajh.27062 · Cited by 2
Enhancing Variant Calling in Whole-exome Sequencing Data Using Population-matched Reference Genomes
Guo, S., Huang, Z., Zhang, Y., He, Y., Chen, X., Wang, W., Li, L. M., Kang, Y., Gao, Z., Yu, J., et al. (2024) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzae070 · Cited by 3
Can molecular patterns help to classify overlapping entities in myeloid neoplasms?
Hoermann, G., & Khoury, J. D. (2024) · Histopathology · doi:10.1111/his.15339 · Cited by 2
Kalmer, M., Graßhoff, M., Maié, T., Pannen, K., Toledo, M. A. S., Vieri, M., Olschok, K., Lemanzyk, R., Lazarevic, J., Junge, B., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024012600 · Cited by 4
High Mobility Group A1 Chromatin Keys: Unlocking the Genome During MPN Progression
Resar, L. M. S., & Luo, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052125 · Cited by 2
Using tumour phylogenies to identify drivers
Koch, L. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00458-9 · Cited by 2
Multiplicity of Time Scales in Blood Cell Formation and Leukemia
Stiehl, T. (2023) · Mathematics online first collections · doi:10.1007/16618_2023_73 · Cited by 2
Yacoub, A., Twardowski, N., Britt, A., & Shraim, N. (2024) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2024.02.015 · Cited by 2
Metadata
- Authors
- Williams, N., Lee, J., Mitchell, E., Moore, L., Baxter, E. J., Hewinson, J., Dawson, K. J., Menzies, A., Godfrey, A. L., Green, A. R., Campbell, P. J., & Nangalia, J.
- Affiliations
- Wellcome Sanger Institute (GB)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- University of Cambridge (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Nangalia, Jyoti
- Venue
- Nature
- Published
- 2022-01-20
- Volume
- 602
- Issue
- 7895
- Pages
- 162-168
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W4205211254
- Cited by
- 285
- References
- 64
- Citations by year
- 2026: 40 · 2025: 52 · 2024: 74 · 2023: 65 · 2022: 52
- FWCI
- 37.71
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Nature (publishedVersion)
- Research Square (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- MPN Research Foundation
- Wellcome Trust (104710/Z/14/Z)
- Cancer Research UK (23917)
- Kay Kendall Leukaemia Fund
- Blood Cancer UK
- Medical Research Council (MC_PC_17230)
- Topics
- Health Sciences › Medicine › Hematology › Myeloproliferative Neoplasms: Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- myeloproliferative neoplasms, driver mutations, clonal evolution, JAK2 V617F mutation, DNMT3A, PPM1D, clonal expansion, mutation timing, carcinogenesis
- MeSH terms
- Protein Phosphatase 2C, Whole Genome Sequencing, Adult, Child, Preschool, Clone Cells, Humans, Mutation, Myeloproliferative Disorders, Neoplasms, Phylogeny, Janus Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
